Article
Structure-based Generation of a Secondary Nucleation Inhibitor in α-Synuclein Aggregation Using a Conditional Diffusion Model
2025-08-17
Abstract excerpt
The process of α -synuclein aggregation results in the formation of amyloid fibrils, which accumulate in the brain of patients affected by Parkinson’s disease. Among possible therapeutic strategies to cure this disease, one approach is based on the development of compounds capable of inhibiting α -synuclein aggregation. An effective inhibition could be achieved by blocking the nucleation sites on the surface of...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bf3ed79f-4936-5f36-b42b-0f0c35aa1af1
- DOI
- 10.1101/2025.08.16.670694
